125 related articles for article (PubMed ID: 9514100)
1. Elevated cyclic AMP suppresses ConA-induced MT1-MMP expression in MDA-MB-231 human breast cancer cells.
Yu M; Sato H; Seiki M; Spiegel S; Thompson EW
Clin Exp Metastasis; 1998 Feb; 16(2):185-91. PubMed ID: 9514100
[TBL] [Abstract][Full Text] [Related]
2. Tyrosine phosphorylation mediates ConA-induced membrane type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in MDA-MB-231 human breast carcinoma cells.
Yu M; Bowden ET; Sitlani J; Sato H; Seiki M; Mueller SC; Thompson EW
Cancer Res; 1997 Nov; 57(22):5028-32. PubMed ID: 9371497
[TBL] [Abstract][Full Text] [Related]
3. MT1-MMP correlates with MMP-2 activation potential seen after epithelial to mesenchymal transition in human breast carcinoma cells.
Pulyaeva H; Bueno J; Polette M; Birembaut P; Sato H; Seiki M; Thompson EW
Clin Exp Metastasis; 1997 Mar; 15(2):111-20. PubMed ID: 9062387
[TBL] [Abstract][Full Text] [Related]
4. Calcium influx inhibits MT1-MMP processing and blocks MMP-2 activation.
Yu M; Sato H; Seiki M; Spiegel S; Thompson EW
FEBS Lett; 1997 Aug; 412(3):568-72. PubMed ID: 9276468
[TBL] [Abstract][Full Text] [Related]
5. Rapid activation of matrix metalloproteinase-2 by glioma cells occurs through a posttranslational MT1-MMP-dependent mechanism.
Gingras D; Pagé M; Annabi B; Béliveau R
Biochim Biophys Acta; 2000 Sep; 1497(3):341-50. PubMed ID: 10996658
[TBL] [Abstract][Full Text] [Related]
6. Heat shock-mediated transient increase in intracellular 3',5'-cyclic AMP results in tumor specific suppression of membrane type 1-matrix metalloproteinase production and progelatinase A activation.
Sawaji Y; Sato T; Seiki M; Ito A
Clin Exp Metastasis; 2000; 18(2):131-8. PubMed ID: 11235988
[TBL] [Abstract][Full Text] [Related]
7. Furin-independent pathway of membrane type 1-matrix metalloproteinase activation in rabbit dermal fibroblasts.
Sato T; Kondo T; Fujisawa T; Seiki M; Ito A
J Biol Chem; 1999 Dec; 274(52):37280-4. PubMed ID: 10601293
[TBL] [Abstract][Full Text] [Related]
8. Complex regulation of membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation by concanavalin A in MDA-MB-231 human breast cancer cells.
Yu M; Sato H; Seiki M; Thompson EW
Cancer Res; 1995 Aug; 55(15):3272-7. PubMed ID: 7614461
[TBL] [Abstract][Full Text] [Related]
9. Paradigmatic identification of MMP-2 and MT1-MMP activation systems in cardiac fibroblasts cultured as a monolayer.
Guo C; Jiang J; Elliott JM; Piacentini L
J Cell Biochem; 2005 Feb; 94(3):446-59. PubMed ID: 15534869
[TBL] [Abstract][Full Text] [Related]
10. Implication of collagen type I-induced membrane-type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in the metastatic progression of breast carcinoma.
Gilles C; Polette M; Seiki M; Birembaut P; Thompson EW
Lab Invest; 1997 May; 76(5):651-60. PubMed ID: 9166284
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro.
Yamamoto M; Mohanam S; Sawaya R; Fuller GN; Seiki M; Sato H; Gokaslan ZL; Liotta LA; Nicolson GL; Rao JS
Cancer Res; 1996 Jan; 56(2):384-92. PubMed ID: 8542596
[TBL] [Abstract][Full Text] [Related]
12. Immunological characterization of cell-surface and soluble forms of membrane type 1 matrix metalloproteinase in human breast cancer cells and in fibroblasts.
Li H; Bauzon DE; Xu X; Tschesche H; Cao J; Sang QA
Mol Carcinog; 1998 Jun; 22(2):84-94. PubMed ID: 9655252
[TBL] [Abstract][Full Text] [Related]
13. [Effects of MT1-MMP on the in vitro invasiveness of breast cancer cells].
Yao GY; Zeng MS; Lin P; Song LB; Zhang X; He JH; Yang MT; Rong TH
Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):650-3. PubMed ID: 17274367
[TBL] [Abstract][Full Text] [Related]
14. Role of tissue inhibitor of metalloproteinases-2 (TIMP-2) in regulation of pro-gelatinase A activation catalyzed by membrane-type matrix metalloproteinase-1 (MT1-MMP) in human cancer cells.
Shofuda K; Moriyama K; Nishihashi A; Higashi S; Mizushima H; Yasumitsu H; Miki K; Sato H; Seiki M; Miyazaki K
J Biochem; 1998 Aug; 124(2):462-70. PubMed ID: 9685743
[TBL] [Abstract][Full Text] [Related]
15. Induction of membrane-type matrix metalloproteinase 1 (MT1-MMP) expression in human fibroblasts by breast adenocarcinoma cells.
Polette M; Gilles C; Marchand V; Seiki M; Tournier JM; Birembaut P
Clin Exp Metastasis; 1997 Mar; 15(2):157-63. PubMed ID: 9062392
[TBL] [Abstract][Full Text] [Related]
16. Necrosis induction in glioblastoma cells reveals a new "bioswitch" function for the MT1-MMP/G6PT signaling axis in proMMP-2 activation versus cell death decision.
Belkaid A; Fortier S; Cao J; Annabi B
Neoplasia; 2007 Apr; 9(4):332-40. PubMed ID: 17460777
[TBL] [Abstract][Full Text] [Related]
17. Concanavalin-A-induced autophagy biomarkers requires membrane type-1 matrix metalloproteinase intracellular signaling in glioblastoma cells.
Pratt J; Roy R; Annabi B
Glycobiology; 2012 Sep; 22(9):1245-55. PubMed ID: 22692046
[TBL] [Abstract][Full Text] [Related]
18. Carbohydrate-mediated regulation of matrix metalloproteinase-2 activation in normal human fibroblasts and fibrosarcoma cells.
Gervasi DC; Raz A; Dehem M; Yang M; Kurkinen M; Fridman R
Biochem Biophys Res Commun; 1996 Nov; 228(2):530-8. PubMed ID: 8920947
[TBL] [Abstract][Full Text] [Related]
19. The biphasic induction of p21 and p27 in breast cancer cells by modulators of cAMP is posttranscriptionally regulated and independent of the PKA pathway.
Rao S; Gray-Bablin J; Herliczek TW; Keyomarsi K
Exp Cell Res; 1999 Oct; 252(1):211-23. PubMed ID: 10502413
[TBL] [Abstract][Full Text] [Related]
20. SPARC/osteonectin induces matrix metalloproteinase 2 activation in human breast cancer cell lines.
Gilles C; Bassuk JA; Pulyaeva H; Sage EH; Foidart JM; Thompson EW
Cancer Res; 1998 Dec; 58(23):5529-36. PubMed ID: 9850090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
